BSE filing, NSE: SMSPHARMA. Summary written from the filing by ALFA Finder's alert engine.
SMS Pharmaceuticals Ltd: key numbers
- Share price
- ₹524.90
- Market cap
- ₹4,653 Cr
- Revenue (annual)
- ₹886.9 Cr
- Net profit (annual)
- ₹102.0 Cr
- P/E (TTM)
- 45.4×Sector 41.3×
- Promoter holding
- 68.07%+0.00% QoQ
- FII holding
- 1.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SMS Pharmaceuticals Ltd
All →SMS Pharmaceuticals Investor Presentation: Key Takeaways
Q2FY27 revenue ₹316 Cr (+30% YoY), EBITDA ₹68 Cr at 21% margin, PAT ₹40 Cr (+57%). Strategy: backward integration, high-value APIs, DMF/CEP filings, ₹280 Cr capex.
SMS Pharmaceuticals Management Change
SMS Pharmaceuticals' Company Secretary Thirumalesh Tumma resigned effective November 4, 2026. Manohar Mollama has been appointed as the new Company Secretary effective November 5, 2026.
SMS Pharmaceuticals Q2 FY27 Results: Net Profit ₹39.9 Cr, Up 57.7% YoY
SMS Pharmaceuticals Ltd reported revenue from operations of ₹316.1 Cr (+30.4% YoY) and net profit of ₹39.9 Cr (+57.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹39.9 Cr · +57.7% YoY
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals received an Income Tax appellate order under Section 250 dismissing its appeal for AY 2018-19. The company says there is no material impact and is reviewing next steps.
- Value
- ₹0.40 Cr
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals disclosed that the CIT(Appeals) dismissed its appeal against a ₹7.19 Crore income tax assessment for AY 2018-19. The company is reviewing the order and expects no material impact.
- Value
- ₹7.19 Cr
SMS Pharmaceuticals Legal & Regulatory
SMS Pharmaceuticals received an Income Tax appellate order allowing its appeal for AY 2023-24. The outstanding tax demand of Rs.45.63 Crore, including interest, stands vacated.
- Value
- ₹45.63 Cr
Other results update announcements
All →KSH International Results Update
KSH International's Q2 FY27 revenue rose 85%, with EBITDA of Rs 897 million and PAT of Rs 480 million. The board also approved a Phase-3 Supa expansion.
Lumino Industries Results Update
Lumino Industries reported Q2 FY27 revenue of Rs 661 crore, up 30% YoY, and PAT of Rs 53 crore. Total order book stood at Rs 2,885 crore.
Colab Platforms Results Update
Colab Platforms issued a press release on H1 FY27 results, with total income up 13.65% year on year. PAT rose 24.88% over the same period.
Shringar House of Mangalsutra Results Update
Shringar House of Mangalsutra issued a press release on Q2 FY27 results, with revenue up 54.8% year on year. Profit after tax rose 73.2% in the quarter.
Robokidz Eduventures Results Update
Robokidz Eduventures' H1 FY27 press release reports total income up 182% and net profit up 395% YoY. These are P&L highlights, with no transaction value.
PDS Results Update
PDS Limited's press release reports record Q2 FY27 revenue of Rs 4,432 crore and PAT up 144% quarter-on-quarter. It also declares an interim dividend of Rs 2.20 per share.